Ceradyne Receives US Marine Corps Developmental Test Helmet Awards(Costa Mesa, Calif. & Salem, N.H., July 23, 2009) -- In response to the U.S. Marine Corps Systems Command (MARCORSYSCOM) solicitation, Ceradyne, Inc. (NASDAQ:CRDN) has been awarded Developmental Test Helmet awards valued at approximately $1.2 million. These test helmets are expected to be delivered within 30 days.
On June 9, 2009, Ceradyne announced that it had acquired substantially all of the business, assets and technology of the Salem, New Hampshire based helmet manufacturer, Diaphorm Technologies, LLC. Simultaneously, Ceradyne announced that it had submitted a response to a Marine Corps solicitation, now in conjunction with the U.S. Army PEO Soldier. The solicitation was for the procurement of Enhanced Combat Helmets (ECH) with the intention to procure prototype combat helmets with the option to field production helmets to both services.
The Global Soldier Modernization Market 2014-2024
This Developmental Test Helmet awards are a direct result of the solicitation. The government has the option of procuring a minimum of 310 helmets and a maximum of approximately 246,840 helmets over the next two years.
As Ceradyne stated in its June 9, 2009 press release, "Ceradyne's strategy is to combine its successful track record in body armor programs with the proprietary helmet-forming technologies of Diaphorm to create a world class manufacturer of Enhanced Combat Helmets. Ceradyne-Diaphorm's Enhanced Combat Helmet will provide substantively increased levels of protection, utilizing high-volume repeatable manufacturing with reliable on-time delivery to support expedited procurements."
David Reed, President of North American Operations, commented: "Our Enhanced Combat Helmet team is very pleased and excited regarding this recent award. This type of product is exactly what we had in mind when we developed our diversification and acquisition strategy-taking advantage of our state-of-the-art ballistic technology in areas of the military where our past performance and quality are already established. This strategy led directly to our recent Diaphorm acquisition.
"Our intention is to maintain the helmet research and development activities in Salem, New Hampshire, and, assuming a production award, implement a production volume helmet line in our state-of-the-art 'lean' armor assembly plant in Irvine, California."
Source : Ceradyne, Inc. (NASDAQ:CRDN)